# Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women

> **NCT03432468** · NA · UNKNOWN · sponsor: **LanZhou University** · enrollment: 102 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Valsartan 1
- **DRUG:** Valsartan 80 mg

## Key facts

- **NCT ID:** NCT03432468
- **Lead sponsor:** LanZhou University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-01
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2018-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03432468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03432468, "Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03432468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*